All terms in NCIT
| Label | Id | Description |
|---|---|---|
| Controlled Release Capsule Dosage Form | NCIT_C69024 | [A capsule designed to release active and/or inert ingredient(s) at a controlled rate.] |
| Capsule Dosage Form | NCIT_C25158 | [A solid contained within either a hard or soft soluble shell, usually prepared from gelatin.] |
| Controlled Release Dosage Form | NCIT_C42731 | [A solid, semi-solid, solution or suspension designed to release active and/or inert ingredient(s) at a controlled rate.] |
| Controlled Release Tablet Dosage Form | NCIT_C69025 | [A tablet designed to release active and/or inert ingredient(s) at a controlled rate.] |
| Tablet Dosage Form | NCIT_C42998 | [A solid composed of a mixture of that active and/or inert ingredient(s) are pressed or compacted together, usually in the form of a relatively flat and round, square or oval shape.] |
| Opioid Rotation | NCIT_C21083 | [Shifting from one opiate to another to maintain effectiveness in analgesia while minimizing the side-effect profile.] |
| Pharmacologic Management | NCIT_C21090 | [A health/illness/pain management principle specifically directed at the management of pharmacologic agents in maximizing beneficial outcomes and minimizing unfavorable effects.] |
| Cancer Pain Management | NCIT_C15633 | [Therapy directed toward reduction and control of cancer pain.] |
| Controlled Release Liquid Dosage Form | NCIT_C69026 | [A solution or suspension designed to release active and/or inert ingredient(s) at a controlled rate.] |
| Liquid Dosage Form | NCIT_C42953 | [A substance in the fluid state of matter having no fixed shape but a fixed volume.] |
| Pain Map | NCIT_C21084 | [Using a drawn representation of the body, patients who are unable to speak mark areas where they feel pain. Some practitioners use colored pencils or crayons to allow patients to color code areas of more or less severe pain.] |
| Suspension for Reconstitution Dosage Form | NCIT_C69027 | [A suspension mixed with a liquid to form a solution or suspension before administration.] |
| Suspension Dosage Form | NCIT_C42994 | [Insoluble solid particles composed of active and/or inert ingredient(s) that are dispersed in a liquid.] |
| Pain Threshold | NCIT_C21085 | [The minimum level of stimulation of a body part that a person will perceive as being noxious or unpleasant. (Taber's)] |
| Personal Attribute | NCIT_C19332 | [The distinguishing qualities or prominent aspects of an individual person.] |
| Solution for Reconstitution Dosage Form | NCIT_C69028 | [A solution intended for reconstitution before administration.] |
| Solution Dosage Form | NCIT_C42986 | [A clear, homogeneous liquid composed of one or more chemical substances dissolved in a solvent or mixture of mutually miscible solvents.] |
| Pain Tolerance | NCIT_C21086 | [The degree of pain an individual can withstand. (Taber's)] |
| DNA Maintenance Process | NCIT_C41543 | [A DNA Maintenance Process consists of activities of biologic molecules, complexes, or subcellular components that preserve DNA integrity through faithful DNA replication, DNA repair, or recombination. (NCI)] |
| Growth Arrest-Specific Protein 8 | NCIT_C21081 | [Growth arrest-specific protein 8 (478 aa, ~56 kDa) is encoded by the human GAS8 gene. This protein may play a role in both cell cycle arrest and microtubule-dependent transport.] |